LA Times cites Downey Obesity Report on FDA decision on Lorcaserin
October 23, 2010 The Los An gels Times has picked up our press release on the FDA decision on lorcaserin. FDA shoots down another weight-loss drug – latimes.com. See the Daily Downey.
View ArticleFDA Panel Approves Obesity Drug
In a surprise vote, the FDA Advisory Committee voted to approve Orexigen Therapeutics obesity drug, Contrave. The vote was 13 to 7. This is the first obesity drug to win approval since 1999. The FDA...
View ArticleArena to Get Second Shot at Approval
Arena Pharmaceuticals Inc. (and its partner Esai Inc.) have announced that they have been informed by the Food and Drug Administration that an Advisory Committee meeting will be held in the second...
View ArticleIRB Raps Obese-trashing Prof
The University of New Mexico has announced that its Institutional review board (IRB) has found that Professor Geoffrey Miller’s tweet telling Ph.D. applicants who were obese not to apply was not...
View Article
